PAPER Dai Y, Zhang M, Shi X, Wang K, Gao G, Shen L, Sun T
SEARCH RESULTS
3953 RESULTS
PAPER de la Torre JC, Olmo AD, Valles S
Can mild cognitive impairment be stabilized by showering brain mitochondria with laser photons?
Neuropharmacology. 2019 Nov 5;:107841. PubMed: 31704275PAPER Franco-Bocanegra DK, George B, Lau LC, Holmes C, Nicoll JA, Boche D
Microglial motility in Alzheimer's disease and after Aβ42 immunotherapy: a human post-mortem study.
Acta Neuropathol Commun. 2019 Nov 8;7(1):174. PubMed: 31703599PAPER Tolar M, Abushakra S, Sabbagh M
The path forward in Alzheimer's disease therapeutics: Reevaluating the amyloid cascade hypothesis.
Alzheimers Dement. 2020 Jan 3; PubMed: 31706733PAPER Swaminathan M, Fung C, Finkelstein DI, Bornstein JC, Foong JP
α-Synuclein Regulates Development and Function of Cholinergic Enteric Neurons in the Mouse Colon.
Neuroscience. 2019 Dec 15;423:76-85. Epub 2019 Nov 6 PubMed: 31705886PAPER Wallings RL, Humble SW, Ward ME, Wade-Martins R
Lysosomal Dysfunction at the Centre of Parkinson's Disease and Frontotemporal Dementia/Amyotrophic Lateral Sclerosis.
Trends Neurosci. 2019 Dec;42(12):899-912. Epub 2019 Nov 5 PubMed: 31704179PAPER Charidimou A
Cerebral amyloid angiopathy-related transient focal neurological episodes (CAA-TFNEs): A well-defined clinical-radiological syndrome.
J Neurol Sci. 2019 Nov 15;406:116496. Epub 2019 Nov 6 PubMed: 31703811PAPER Ko YH, Kwon SH, Kim SK, Lee BR, Hur KH, Kim YJ, Kim SE, Lee SY, Jang CG
Protective effects of 6,7,4'-trihydroxyisoflavone, a major metabolite of daidzein, on 6-hydroxydopamine-induced neuronal cell death in SH-SY5Y human neuroblastoma cells.
Arch Pharm Res. 2019 Dec;42(12):1081-1091. Epub 2019 Nov 8 PubMed: 31705299PAPER Benkert J, Hess S, Roy S, Beccano-Kelly D, Wiederspohn N, Duda J, Simons C, Patil K, Gaifullina A, Mannal N, Dragicevic E, Spaich D, Müller S, Nemeth J, Hollmann H, Deuter N, Mousba Y, Kubisch C, Poetschke C, Striessnig J, Pongs O, Schneider T, Wade-Martins R, Patel S, Parlato R, Frank T, Kloppenburg P, Liss B
Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson's disease.
Nat Commun. 2019 Nov 8;10(1):5094. PubMed: 31704946PAPER Huebecker M, Moloney EB, van der Spoel AC, Priestman DA, Isacson O, Hallett PJ, Platt FM
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease.
Mol Neurodegener. 2019 Nov 8;14(1):40. PubMed: 31703585PAPER von Rüden EL, Zellinger C, Gedon J, Walker A, Bierling V, Deeg CA, Hauck SM, Potschka H
Regulation of Alzheimer's disease-associated proteins during epileptogenesis.
Neuroscience. 2020 Jan 1;424:102-120. Epub 2019 Nov 6 PubMed: 31705965PAPER Bamford RA, Widagdo J, Takamura N, Eve M, Anggono V, Oguro-Ando A
The Interaction Between Contactin and Amyloid Precursor Protein and Its Role in Alzheimer's Disease.
Neuroscience. 2020 Jan 1;424:184-202. Epub 2019 Nov 6 PubMed: 31705890PAPER Chen Y, Gao X, Liu Q, Zeng L, Zhang K, Mu K, Zhang D, Zou H, Wu N, Ou J, Wang Q, Mao S
Alpha-asarone improves cognitive function of aged rats by alleviating neuronal excitotoxicity via GABAA receptors.
Neuropharmacology. 2020 Jan 1;162:107843. Epub 2019 Nov 5 PubMed: 31704273PAPER Kawazoe M, Arima H, Maeda T, Tsuji M, Mishima T, Fujioka S, Tsugawa J, Tsuboi Y
Sensitivity and specificity of cardiac 123I-MIBG scintigraphy for diagnosis of early-phase Parkinson's disease.
J Neurol Sci. 2019 Dec 15;407:116409. Epub 2019 Jul 24 PubMed: 31706063PAPER Samoudi G, Nilsson A, Carlsson T, Bergquist F
c-Fos Expression after Stochastic Vestibular Stimulation and Levodopa in 6-OHDA Hemilesioned Rats.
Neuroscience. 2020 Jan 1;424:146-154. Epub 2019 Nov 6 PubMed: 31704349Current Filters
- Date Range : Aug 2019 to Nov 2019 x